4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0001062993-23-017413
Director sold 8,939 shares at $80.32 ($717,959)
- Director acquired 32,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nusse Roeland Director | 2023-08-30 | Option exercise | +16,000 | $21.85 | $349,600 | 44,811 | D |
| Nusse Roeland Director | 2023-08-30 | Option exercise | +16,000 | $22.95 | $367,200 | 60,811 | D |
| Nusse Roeland Director | 2023-08-30 | Sale | −8,939 | $80.32 | $717,959 | 51,872 | D |
| Derivatives | |||||||
| Nusse Roeland Director | 2023-08-30 | Option exercise · Stock Options (Right to Buy) | −16,000 | 0 | D | ||
| Nusse Roeland Director | 2023-08-30 | Option exercise · Stock Options (Right to Buy) | −16,000 | 0 | D | ||
| Open-market sales · 8,939 sh · avg $80.32 · $717,959 | |||||||
Loading xslF345X05/form4.xml…